Insider screener

Period: 12 months Type of trade: Sold × Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20,514 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20,514 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20,514 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20,514 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20,514 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20,514 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20,514 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Ryan B Bell President, MCM
Sold on a plan 4×
$499.84K 7,240 at 69.04
13.1%
Planned (10b5-1)
2 Mar 2026
Jared Gollob Chief Medical Officer
Sold at will 3×
$499.15K 5,613 at 88.93
4.4%
Not planned
2 Mar 2026
Everett Neville See Remarks
Sold on a plan
$496.64K 1,719 at 288.91
23.3%
Planned (10b5-1)
2 Mar 2026
Sunil Sajnani Chief Audit/LP Executive
Sold at will
$491.13K 18,353 at 26.76
17.7%
Not planned
2 Mar 2026
William Jacob Savage Chief Medical Officer
Sold on a plan 2×
$486.07K 7,378 at 65.88
8.0%
Planned (10b5-1)
2 Mar 2026
Phillip G. Febbo Chief Scientific & Med Officer
Sold on a plan
$485.43K 13,425 at 36.16
10.3%
Planned (10b5-1)
2 Mar 2026
Quentin A. Fendelet Corp. VP - CAO
Sold at will 2×
$470.65K 2,299 at 204.72
100%
Sold half or more
2 Mar 2026
Adam Karon COO & GM Edge Technology Group
Sold on a plan
$458.19K 4,728 at 96.91
20.6%
Planned (10b5-1)
2 Mar 2026
Derek G. Solon Senior Vice President
Sold at will
$452.44K 6,000 at 75.41
10.5%
Not planned
2 Mar 2026
Joy Liu EVP and Chief Legal Officer
Sold on a plan
$442.40K 892 at 495.96
3.8%
Planned (10b5-1)
2 Mar 2026
Mary-Lee Stillwell SVP and Controller
Sold on a plan
$428.45K 8,569 at 50.00
16.4%
Planned (10b5-1)
2 Mar 2026
DENNIS P McNAMARA Secretary
Sold at will
$423.70K 4,673 at 90.67
18.8%
Not planned
2 Mar 2026
Daniel Breeze SVP Corp Dev of RGLD Gold AG
Sold at will 2×
$421.21K 1,400 at 300.87
6.5%
Not planned
2 Mar 2026
Nicholas Corcoran See remarks
Sold at will
$412.63K 2,966 at 139.12
9.0%
Not planned
2 Mar 2026
Javier Olivan Chief Operating Officer · indirect
Sold on a plan 4×
$400.81K 629 at 637.21
18.2%
Planned (10b5-1)
2 Mar 2026
Steven Yi See Remarks
Sold on a plan
$392.00K 39,252 at 9.99
1.5%
Planned (10b5-1)
2 Mar 2026
Dennis W. Liu Chief Accounting Officer
Sold on a plan
$386.13K 7,950 at 48.57
42.0%
Planned (10b5-1)
2 Mar 2026
Steven M Chaouki President, US Markets
Sold on a plan
$383.20K 5,000 at 76.64
5.0%
Planned (10b5-1)
2 Mar 2026
Michael Derstine EVP and Chief Risk Officer
Sold at will
$379.92K 9,000 at 42.21
18.7%
Not planned
2 Mar 2026
Robert Edward Hensley EVP & Chief Investment Officer
Sold at will
$372.62K 2,569 at 145.04
17.2%
Not planned
2 Mar 2026
Michael Halpin Chief Operating Officer
Sold on a plan
$363.77K 10,305 at 35.30
39.1%
Planned (10b5-1)
2 Mar 2026
Sumi Shrishrimal EVP, Chief Risk Officer
Sold at will 3×
$363.48K 2,830 at 128.44
6.3%
Not planned
2 Mar 2026
Timothy Williams SVP & General Counsel
Sold at will
$350.76K 42,434 at 8.27
10.1%
Not planned
2 Mar 2026
Gunther Birznieks SVP, Business Development
Sold at will
$350.73K 42,431 at 8.27
7.9%
Not planned
2 Mar 2026
Sean Woodroffe EVP, Ch Ppl Comms Ent Srvc Off
Sold at will
$344.60K 10,000 at 34.46
4.6%
Not planned
2 Mar 2026
Sharon Briansky SVP, GC and Secretary
Sold at will
$340.45K 9,727 at 35.00
10.4%
Not planned
2 Mar 2026
Anil Chitkara Founder & Chief Growth Officer
Sold at will
$330.45K 63,670 at 5.19
4.5%
Not planned
2 Mar 2026
Mario Schlosser President of Technology & CTO
Sold on a plan
$325.85K 24,335 at 13.39
4.5%
Planned (10b5-1)
2 Mar 2026
Stephen R Palmer Vice President of Accounting
Sold on a plan
$324.84K 1,000 at 324.84
2.7%
Planned (10b5-1)
2 Mar 2026
Jose N Reyes Jr Chief Technology Officer · indirect
Sold at will
$317.12K 25,951 at 12.22
8.8%
Not planned
2 Mar 2026
Celia Karam Pres, Retail Bank
Sold on a plan
$312.48K 1,636 at 191.00
2.6%
Planned (10b5-1)
2 Mar 2026
Tonya Stevens CVP, Chief Accounting Officer
Sold on a plan 2×
$308.08K 3,230 at 95.38
4.9%
Planned (10b5-1)
2 Mar 2026
Rifat Kerim Akgonul Chief Product Officer
Sold at will
$306.90K 7,000 at 43.84
6.5%
Not planned
2 Mar 2026
Paul Cunningham Sr. Vice President
Sold on a plan
$297.78K 1,000 at 297.78
1.1%
Planned (10b5-1)
2 Mar 2026
Courtney Gentleman See remarks
Sold on a plan
$293.73K 4,338 at 67.71
17.9%
Planned (10b5-1)
2 Mar 2026
Kevin James Gorman VP & Chief Accounting Officer
Sold at will
$288.57K 1,344 at 214.71
92.2%
Sold half or more
2 Mar 2026
Kade Ross Chief Information Officer
Sold on a plan
$283.94K 19,000 at 14.94
20.5%
Planned (10b5-1)
2 Mar 2026
Melanie Rakita Vice President & CHRO
Sold on a plan
$278.11K 751 at 370.32
15.4%
Planned (10b5-1)
2 Mar 2026
Clayton Scott Chief Commercial Officer
Sold at will
$274.68K 22,478 at 12.22
14.5%
Not planned
2 Mar 2026
Mark C Rodgers MD, Africa-Asia Pacific
Sold on a plan
$268.97K 2,051 at 131.14
7.0%
Planned (10b5-1)
2 Mar 2026
Craig C. Hopkinson EVP R&D, Chief Medical Officer
Sold on a plan
$267.49K 9,000 at 29.72
9.1%
Planned (10b5-1)
2 Mar 2026
John C Ivascu EVP, General Counsel & CCO
Sold at will
$263.56K 4,392 at 60.01
5.1%
Not planned
2 Mar 2026
Darrell Owens See remarks
Sold on a plan
$261.70K 3,865 at 67.71
18.1%
Planned (10b5-1)
2 Mar 2026
Joakim Wijkstrom SVP, Chief Marketing Officer
Sold at will
$254.59K 30,800 at 8.27
8.5%
Not planned
2 Mar 2026
Kevin Christopher Siebert SVP Gen. Counsel & Secretary
Sold at will
$252.64K 7,264 at 34.78
20.4%
Not planned
2 Mar 2026
Josh D. Paul Chief Accounting Officer
Sold on a plan
$251.43K 1,700 at 147.90
2.8%
Planned (10b5-1)
2 Mar 2026
Adam McAnaney Chief Legal Officer
Sold on a plan
$250.53K 18,710 at 13.39
7.6%
Planned (10b5-1)
2 Mar 2026
Michael J Kasbar Executive Chairman
Sold on a plan
$250.20K 10,000 at 25.02
0.9%
Planned (10b5-1)
2 Mar 2026
Kurt Pletcher Chief Legal Officer
Sold on a plan
$249.53K 259 at 963.43
6.0%
Planned (10b5-1)
2 Mar 2026
Ryan Damon Chief Legal Officer
Sold at will
$240.80K 13,385 at 17.99
10.4%
Not planned
Showing 13,901–13,950 of 20,514. ← Newer Page 279 of 411 Older →